<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>İmmünometabolizma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immunometabolizma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 04 Jan 2026 06:45:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>İmmünometabolizma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Genetic Diversity Links FFAR3 to ILC2 Reprogramming</title>
		<link>https://bioengineer.org/genetic-diversity-links-ffar3-to-ilc2-reprogramming/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 04 Jan 2026 06:44:32 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Anti-enflamatuar tedaviler]]></category>
		<category><![CDATA[FFAR3]]></category>
		<category><![CDATA[Genetik çeşitlilik]]></category>
		<category><![CDATA[ILC2 reprogramming]]></category>
		<category><![CDATA[İmmünometabolizma]]></category>
		<guid isPermaLink="false">https://bioengineer.org/genetic-diversity-links-ffar3-to-ilc2-reprogramming/</guid>

					<description><![CDATA[In an era where the intricate interplay between genetics and immune regulation continues to unravel new therapeutic avenues, the recent study led by Rusznak, Toki, Hao, and colleagues at the forefront of immunogenetic research has shed substantial light on the role of FFAR3 in modulating innate lymphoid cells type 2 (ILC2) function. Published in Nature [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313465</post-id>	</item>
	</channel>
</rss>
